Pharma, biotech and medical devices
What are the odds for a drug entering trials?
Bar chart: Chance of moving to the next phase, all drugs, 2011 to 2020. Values in percent. Phase I to Phase II: 52; Phase II to Phase III: 28.9; Phase III to filing for approval: 57.8; Filing to approval: 90.6.
Source: BIO, Informa Pharma Intelligence and QLS Advisors, Clinical Development Success Rates 2011 to 2020. Rates differ a lot by disease area.
The prompt
Using the phase success rates in the chart above, what is the chance that a drug entering Phase I is approved, and the chance for a drug entering Phase II?
Before you reveal anything, plan your own structure and first move on paper. Then reveal one part at a time and compare.